Baillie Gifford & CO Rx Sight, Inc. Transaction History
Baillie Gifford & CO
- $128 Billion
- Q3 2025
A detailed history of Baillie Gifford & CO transactions in Rx Sight, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 686,316 shares of RXST stock, worth $5.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
686,316
Previous 468,945
46.35%
Holding current value
$5.82 Million
Previous $6.1 Million
1.2%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RXST
# of Institutions
183Shares Held
36.6MCall Options Held
42.2KPut Options Held
103K-
Ra Capital Management, L.P. Boston, MA3.7MShares$31.4 Million1.05% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$20.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$19.3 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$15 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.32MShares$11.2 Million0.01% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $234M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...